Stay Updated with the Latest Jazz Pharmaceuticals plc JAZZ News in Real Time
Find JAZZ news now at Meyka AI. Stay informed with the latest Jazz Pharmaceuticals plc stocks updates, including price news, market analysis, and expert insights.
Roche Share Price Dips After UBS Downgrade to Neutral
UBS cut Roche to Neutral on November 2 but raised its target to CHF 420. We explain why the Roche share price slipped to CHF 397.20, what giredestrant means and what analysts expect next.
Dolores Huerta Dies at 96: The Farm Worker Icon’s Life and Legacy
Dolores Huerta, United Farm Workers co-founder, has died at 96. We look at her life, the grape strike, the laws she shaped, and her legacy.
Shell Greenlights $33B LNG Canada Phase 2, Doubling Export Capacity to 28 Mtpa
Shell approves $33 billion LNG Canada Phase 2 expansion on September 29, doubling facility capacity to 28 mtpa by early 2030s. Meyka grades SHEL as A-rated Buy with 12-month forecast at $91.95.
US Trade Deficit Hits $88.6B in July as AI Chip Imports Surge
US trade deficit reached $88.6 billion in July 2026, up 24% from June. AI-driven demand for semiconductors and computers pushed imports to record highs while exports fell 2.1%.
Netflix’s Raygun Documentary Drops September 1: Breaking Badly Tells Her Side
Netflix’s Untold: Raygun Breaking Badly premiered September 1, 2026. The documentary follows Australian breakdancer Rachael Gunn’s controversial 2024 Paris Olympics routine and addresses cheating allegations that spread online.
Air Canada Faces Crisis as FAA Fires Controllers Over LaGuardia Crash Negligence
FAA fires LaGuardia air traffic controllers who left early before deadly Air Canada crash. Two pilots killed in March 22 collision. Staffing crisis deepens.
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…
Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update
Moderna jumped 177% to $174.38 after Phase 3 melanoma vaccine trial success with Merck. The mRNA therapy reduced recurrence risk and represents the first approved late-stage cancer vaccine.
AstraZeneca (LON: AZN) Halts Phase 3 Lung Cancer Trial After Volrustomig Fails to Show Survival Benefit
AstraZeneca has halted a late-stage trial of its lung cancer drug Volrustomig, marking a fresh pipeline setback. The FTSE 100 company said the drug, combined with chemotherapy, was unlikely to improve survival rates. An Independent Data Monitoring Committee recommended stopping the Phase 3 trial after a planned review. This marks AstraZeneca’s second major trial halt…